> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Ceclor Not Withdrawn Due to Safety/Efficacy
- URL: https://www.fdaweb.com/ceclor-not-withdrawn-due-to-safety-efficacy/
- Published: 2021-07-29T12:00:00.000Z
- Updated: 2026-09-14T17:08:28.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5149816

*Federal Register* notice: FDA determines that Eli Lilly’s Ceclor CD (cefaclor extended-release tablets) 375 mg and 500 mg were not withdrawn from sale for reasons of safety or effectiveness, except for the indication “secondary bacterial infections of acute bronchitis.